Helminth egg derivatives as pro-regenerative immunotherapies
D. R. Maestas, L. Chung, J. Han, X. Wang, S. D. Sommerfeld, E. Moore, H. Hieu Nguyen, J. C. Mejias, A. N. Pena, H. Zhang, J. S. T. Hooks, A. F. Chin, J. I. Andorko, C. Berlicke, K. Krishnan, , J. H. Elisseeff
This study develops a regenerative immunotherapy using helminth-derived soluble egg antigen to promote tissue repair in multiple injury models.
bioRxiv · May 2, 2022 · PreprintBioengineering